The 14th Global Drug Delivery Formulation Summit is the leading event to look at innovative solutions and the greatest challenges in pharmaceutical development today.

Going to the summit?

The event will highlight pharmaceutical development challenges from small molecules and biologics, new technologies with concepts and case studies being presented in a number of innovative areas.

Cambridge Consultants' Tim Phillips, Principal Human Factors Expert, will be presenting on the key area for innovation in minimally invasive drug delivery.

Direct-to-Organ Drug Delivery – Opportunities, Challenges, and Ideas.

Date | 18 September 2023
Time | 10:20 – 10:50 am EST
Track | Solution Spotlights
Speakers | Tim Phillips, Principal Human Factors Expert, Cambridge Consultants  

The R&D pipeline across the biopharma industry is diversifying at a rapid pace with new modalities and new classes of drugs becoming a significant part of their overall research strategy. Increasingly we are observing a need for delivering drugs locally in difficult-to-access anatomy such as heart, brain, spine, and kidneys across different therapeutic areas including oncology, CNS, autoimmune and a number of rare diseases. The preference will always be to deliver these drugs with a minimally invasive approach. Our team evaluated the challenges involved in developing device technologies and new procedures for delivering such complex drugs localized to organs, tumours or tissues and developed innovative ideas and concepts that could be deployed in specific situations. This talk will focus on a few select ideas and our thought process in the design and development of such delivery platforms and procedures.


The Westin Copley
10 Huntington Ave
MA 02116
United States


Tim Phillips

Principal Human Factors Expert

Tim is a Principal Human Factors Engineer within the User Centred Design team at Cambridge Consultants, UK. He holds a MSc. in Ergonomics & Human Factors and a BEng. in Design Engineering. He has been working in medical product development for over a decade, having lead roles in the development and validation of numerous surgical, drug delivery, and acute care systems. Tim has cultivated a particular interest in the design and risk management of complex systems.

Related insights


Engineering the future of innovations in oncology

2020년 08월 27일

This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery. 

  • 머신 러닝 & AI
  • Bioinnovation
  • 디지털 헬스
  • 분사기술 (Dispense)
  • 로봇 공학
  • 센서

Drug delivery to the eye: overcoming the challenges of intravitreal prefilled syringes

2021년 02월 25일

Intravitreal Injection Syringe: It is merely a pre-filled syringe, but is it?

  • 디지털 헬스
  • 인간 공학
  • 자연 과학

Our four iF DESIGN AWARDS put us in the top three nationally

2021년 05월 5일

Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.

  • 인간 공학
  • 산업 디자인
  • 사용자 경험

이벤트 보기

UAS Summit & Expo 2023

UAS Summit & Expo 2023

2023년 10월 9일 - 2023년 10월 11일
The Alerus Center, North Dakota

The UAS Summit & Expo situated in the Northern Plains of North Dakota has become a yearly major event for UAS experts from around the world. It’s the original epicenter of drone research, earned its place as the Silicon Valley of Drones and is known to be America’s UAS proving grounds.

European Forum For Industrial Biotechnology & The Bioeconomy 2023

European Forum for Industrial Biotechnology & The Bioeconomy 2023

2023년 10월 24일 - 2023년 10월 25일
De Doelen ICC, Rotterdam

EFIB brings together professionals from across the value chain, including researchers, policy makers, regulators, and global organisations, to discuss advancements in industrial biotechnology and its contribution towards positioning Europe as a global leader in addressing societal and sustainability challenges.